Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.18 AUD -5.26% Market Closed
Market Cap: 189.3m AUD
Have any thoughts about
Arovella Therapeutics Ltd?
Write Note

Arovella Therapeutics Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arovella Therapeutics Ltd
Cost of Revenue Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
VLS

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Arovella Therapeutics Ltd
ASX:ALA
Cost of Revenue
AU$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Cost of Revenue
-AU$169.6m
CAGR 3-Years
8%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Probiotec Ltd
ASX:PBP
Cost of Revenue
-AU$155m
CAGR 3-Years
-28%
CAGR 5-Years
-26%
CAGR 10-Years
-15%
Vita Life Sciences Ltd
ASX:VLS
Cost of Revenue
-AU$32.8m
CAGR 3-Years
-19%
CAGR 5-Years
-19%
CAGR 10-Years
-12%

See Also

What is Arovella Therapeutics Ltd's Cost of Revenue?
Cost of Revenue
0 AUD

Based on the financial report for Jun 30, 2024, Arovella Therapeutics Ltd's Cost of Revenue amounts to 0 AUD.

Back to Top